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1. Introduction 
Wound fluid seems -at least theoretically- easily accessible and might open a new window 
to the local wound microenvironment that cannot be evaluated by the analysis of serum or 
plasma markers. Recently, this strategy has been supported by a first time wound fluid 
proteome analysis comparing acute and chronic wounds (Eming et al. 2010). Interestingly, 
there seem to be essential differences with respect to wound fluid protein composition when 
comparing acute and chronic wounds. The wound fluid proteome of healing tissue is 
characterised by proteins involved in tissue growth and protection from inflammatory 
activity, whereas non-healing wounds are characterised by a chronic inflammatory 
environment primarily consisting of leukocyte proteases and inflammatory mediators 
(Eming et al. 2010). This is particularly striking since the non-healing state in diabetic foot 
ulcers has previously been linked to persistent inflammatory activity (Acosta et al. 2008). 
Thus, the wound fluid of chronic wounds seems to be characterised by an altered wound 
micro-milieu and may, therefore, provide deeper insights into the causes of delayed wound 
healing. 
Tissue repair can be clearly characterised as an ubiquitous process and a wound is more 
precisely described as a transitional tissue rather than a static tissue. Physiological wound 
healing can be recognised as continuous change, which might be seen as a dynamic and 
interactive process resulting in remodelling and tissue restitution. This nature of transitional 
tissues comes down to the difficulty of obtaining appropriate sample materials. 
Nevertheless, the classical phases of healing are useful as a broad roadmap of the course of 
healing, since more precise models and clear landmarks are not available. The historical 
view on wound healing categorises the healing process in separate phases: starting with 
acute injury > I. coagulation > II. an early inflammatory phase > III. a late inflammatory 
phase > IV. a proliferative phase, and > V. remodelling, which ends with tissue restitution 
(Velnar, Bailey, and Smrkolj 2009). 
www.intechopen.com
 
Global Perspective on Diabetic Foot Ulcerations 
 
48
Changes in wound fluid markers, cytokines or cell populations are more suitable for 
describing the local wound microenvironment than are alterations of systemic markers. The 
nature of systemic serum-based markers is likely the sum of different effects all over the 
body. Of course distinct and rather exceptional markers obtained from blood -such as PSA 
(prostate specific antigen) (Balk, Ko, and Bubley 2003) or troponin- have been proven to be 
tissue specific (Apple 1999) and can therefore reveal insights into local processes. However, 
most of the markers found in the bloodstream instead result from systemic alterations rather 
than from local changes. Wound healing takes place simultaneously at a variety of locations 
in the body. Therefore, the impact of serum markers on the assessment of the wound 
microenvironment is questionable so long as there is no systemic affection by septicaemia. 
In addition, many systemic inflammatory markers are altered in response to a variety of 
immune mediators which in turn are triggered by inflammatory events somewhere in the 
body. In this context, the secretion of CRP by the liver upon stimulation by circulatory 
cytokines such as IL-6 (Pepys and Hirschfield 2003) can be exemplified. In line with this 
concept, several studies evaluating CRP as a valuable marker of infection in diabetic foot 
ulcers were judged to be unable to underline its sole effectiveness (Dinh, Snyder, and Veves 
2010). 
Since most systemic markers do not exhibit clear tissue specificity, it might be of special 
interest to gain insights into the local wound microenvironment by assessing biochemical 
markers in wound fluid, which in turn might give us a clue about the local processes 
reflecting the current status of wound healing.  
In the diabetic foot in particular -which is characterised by delayed healing- local 
biomarkers facilitating the evaluation of the wound may be of great clinical value. Being 
able to determine the probability of healing and the risk of infection by assessing markers in 
wound fluid might have a great impact on clinical practice. 
2. Wound fluid 
Wound fluid is an interesting object of investigation because its composition is influenced 
by the state of the wound and the phase of healing (Mani 1999; Trengove, Langton, and 
Stacey 1996). Wound fluid generally consists of an inhomogeneous mixture of different 
endogenous and exogenous sources. It is constituted by a provisional matrix of exudates or 
transudates that originate from the blood, which in turn has already been altered by 
multiple independent pathologic and physiological factors (such as cardiac failure or 
hydration status as well as vasoconstriction or diabetes). In addition, wound fluid 
composition is further modified by factors which are secreted by local cells in the wound or 
by cells that migrate into the wound, as well as by supplementary factors derived from 
microbial contamination. Since the wound cellular population is constantly changing during 
the physiological course of healing, wound fluid should exhibit altered characteristics over 
time (especially regarding its proteome). 
Ideally, wound fluid should be collected non-invasively and with little effort, resulting in a 
better patient as well as greater physician acceptance. This is in contrast to tissue biopsies or 
techniques -which are defined as the gold standard in animal models- such as 
subcutaneously implanted wire mesh cylinders (Hunt Schilling Cylinders), which are 
inadequate for monitoring wound healing in humans (Hunt et al. 1967; Schilling, Joel, and 
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Shurley 1959). Thus, non-invasive techniques hold a relevant advantage for the future, 
allowing the assessment of longitudinal profiles and changes in wound fluid composition. 
2.1 Sampling techniques 
2.1.1 Sampling of chronic wound fluids 
Covering wounds with occlusive dressings and harvesting the accumulated exudate 
underneath is probably the most common technique for obtaining wound fluid in chronic 
wounds. Various modifications of this technique have been described with respect to used 
materials, patient preparation and time scales, as well as with respect to wound bed 
preparation (Trengove et al. 1999; Trengove, Bielefeldt-Ohmann, and Stacey 2000; Yager et 
al. 1996; Wysocki and Grinnell 1990; James et al. 2000; Wallace and Stacey 1998; Chen et al. 
1997; Wysocki et al. 1999; Gohel et al. 2008). Even very comprehensive protocols aiming for 
standardisation have been proposed, including the prior fasting of patients for eight hours 
as well as grading their hydration status by drinking one litre of water while hanging down 
the leg (Trengove, Langton, and Stacey 1996). However, this is not suitable for daily clinical 
routines. In addition, there is also major variability with respect to the time frames defined 
for exudate accumulation, ranging from about one hour (Trengove et al. 1999) to five days 
(Ono et al. 1994). Therefore, the technique of wound fluid collection may indeed impact 
upon subsequent analytic results.  
For chronic wounds in particular, techniques for harvesting even small amounts of wound 
fluid directly from the wound surface have been described. For this purpose, blunt-end 
glass micro-capillaries have been used to collect fluid directly from the wound surface 
(Weckroth et al. 1996). In venous leg ulcers, even the manual expression of wound fluid 
from absorptive dressings has been proposed (Hoffman, Starkey, and Coad 1998). 
Another method for obtaining wound fluid is to cover the wound surface with different 
types of dressings from which it is then mechanically extracted. In the past, this particular 
technique has frequently been modified. Protocols describing the extraction of fluids 
directly from dressings have been reported multiple times (Fivenson et al. 1997; Seah et al. 
2005). For example, wound exudate trapped in a foam dressing has been obtained by 
squeezing the dressing material through a syringe (Seah et al. 2005).  
Another option is placing a sterile mesh onto the wound which absorbs the wound fluid 
into a sterilised pre-weighed whatman paper, which was described as allowing the recovery 
of 50-200µl of sample material. Subsequently, wound fluid was extracted from the filters by 
washouts employing a suitable buffer (Moor, Vachon, and Gould 2009). Similarly, glass 
microfibre circle filters were inserted into wound centres in order to saturate for 2 hours 
with wound exudate. Wound fluid was then extracted by phosphate buffered saline 
(Schmidtchen 2000).  
A further technique described for the acquisition of wound fluid is a modification of the 
methodology used by the Schirmer´s test, which was originally invented to measure tear 
secretion in an ophthalmologic setting (Schirmer 1903, cited by Kallarackal et al. 2002). This 
attempt consists of absorbent paper strips which are placed on the wound surface thereby 
soaking with fluid for 5 minutes. Subsequently, the sample material is recovered by stirring 
the paper strips in a buffer for 2 hours (Muller et al. 2008). 
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Also, hydrophilic dextranomer beads layered on wounds have been used. In preliminary 
experiments with defined amounts of proteins, a recovery of 88-98% was described when 
extracting the beads with equal volumes of phosphate buffered saline for 12 hours (Cooper 
et al. 1994). 
One potential drawback to these approaches is the issue of sample dilution, thus altering the 
analyte containing matrix as well as leaving the precise amount of fluid enclosed and 
remaining in the dressing material undetermined. Furthermore, huge inter-patient 
variability in cytokine concentrations -possibly due to technical problems during wound 
fluid aspiration from under occlusive Tegaderm® dressings- was observed in one study 
(Gohel et al. 2008). 
To overcome the obstacles of methodological limitations in sample material and sampling 
difficulties, a technique using washouts of wound areas by the application of 5ml of sterile 
saline to wounds and subsequent collection of the fluid again by needle aspiration has been 
proposed (Ambrosch et al. 2008). However, a relevant dilution of the sample may again 
occur and so exert undetermined effects on the original fluid matrix.  
Microdialysis has also been proposed for collecting wound fluid. However, this is an 
invasive technique and it is not undisputed since the insertion of foreign material may affect 
the wound microenvironment and induce confounding effects on the expression of 
signalling molecules (Stenken et al. 2010; Mellergard et al. 2008). Nevertheless, this 
technique is well established for sampling the fluid of the interstitial space and the samples 
obtained are usually of high quality (Simonsen et al. 1998; Clough and Noble 2003).  
A possible major issue in all these techniques -covering wounds with foreign material to a 
minor or major extent- is the fact that the collection  materials may influence the biochemical 
or immunological properties of the wound (Schmidtchen 2000; Hoffman, Noble, and Eagle 
1999) or else interfere with the analytes that are to be measured.  
Given these findings, we have considered implementing a novel way of obtaining wound 
fluid which might overcome some of the shortcomings of the earlier proposed techniques. 
Being convinced that wound fluid is a complex substrate (displaying the recent condition of 
the wound healing process), the sample material should be rapidly harvested within a short 
processing time so as to remain unaltered. The new protocol should be neither time-
consuming nor cause much logistical effort, and thereby be suitable for daily clinical 
routines. 
The issue of limited sample volumes is diminishing in importance since novel analytic 
techniques and devices still provide good and reproducible measurements, even when 
using very little amounts of fluid (see section 4). However, the issue of acquiring suitable 
and high-quality material in a reproducible, standardised manner is increasingly relevant 
and has been sought for years (Yager, Kulina, and Gilman 2007). 
Therefore, we performed wound swabs without pressure using micro-flocked swabs 
(Minitip Flocked Swabs; nylon flocked swabs with moulded breakpoint, MicroRheologics, 
Brescia, Italy) that adsorb the wound exudate through capillary action, coating nylon fibres 
without entrapment. In our setting, wound fluid was collected from diabetic foot ulcers by 
swabbing -after sharp debridement and haemostasis- using the Levine technique (Wound 
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infection in clinical practice. An international consensus 2008). Subsequently, the wound 
fluid was recovered by immediate centrifugation of swab tips at 10 000 rpm for 3 minutes at 
room temperature, using eppendorf cups equipped with a filter to hold the swab tip in place 
(Oxy Fill centrifugal filters without RoTrac capillary pore membrane, Carl Roth GmbH, 
Karlsruhe, Germany). The resulting cell free supernatant could then be used for subsequent 
analysis (Löffler et al. 2011). 
2.1.2 Sampling of acute wound fluids 
Techniques for harvesting acute wound fluid usually differ considerably from the methods 
described above for chronic wounds. This can be attributed to the different availability of 
wound exudates in the acute setting, as well as the different time frame until tissue 
restitution is reached. In several studies, wound fluid was obtained from suction drains, 
which have been inserted intra-operatively (Yager et al. 1996; Trengove et al. 1999; Baker 
and Leaper 2000). The collection of blister fluid is another opportunity for acquiring sample 
material (Oono et al. 1997; Ortega, Ganz, and Milner 2000).  
Negative pressure therapy (Vacuum Assisted Closure, V.A.C.) permits additional access to 
wound fluid (Duckworth et al. 2004), which is also a suitable technique in diabetic foot 
ulcers (Noble-Bell and Forbes 2008). However, in this setting the disparity between methods 
seems quite obvious, so long as rather passive methods are compared to negative pressure 
therapy (Yager, Kulina, and Gilman 2007). Wound fluid obtained by V.A.C. therapy is 
characterised by an increased protein concentration. In a study of Dealey et al., the attempt 
to establish a suitable and valid technique for comparison failed due to technical reasons, 
causing the cessation of a second study arm (Dealey, Cameron, and Arrowsmith 2006).  
Nevertheless, when interpreting the results with some caution, comparisons of the values from 
acute and chronic wound fluid can be worthwhile and can give important hints as to the 
differences between non-healing and healing wounds. Furthermore, the opportunity of 
analysing wound fluid over time will surely facilitate the discovery of relevant healing factors.  
3. Sample requirements and challenges dependent on the choice of analytes 
Besides all the obstacles that have been experienced in harvesting wound fluid and the 
interconnected high logistical effort to some extent also with respect to patient preparation, it 
is reasonable to assume that the sampling technique itself is likely to influence subsequent 
analysis.  
So far, there is no gold standard to which a new sampling technique could be referenced to, 
nor any overview of the different methods that could elucidate the advantages and 
disadvantages of each particular technique. This lack of knowledge, along with the inherent 
variations in wound fluid composition -particularly in chronic wounds- complicates the 
picture and renders wound fluid a fairly complex analytic material. The missing 
standardisation in sampling wound fluid is likely to result in wound fluid being seen as an 
undefined soup, as termed decades ago by Trengove et al. (Trengove, Langton, and Stacey 
1996). However, wound fluid might also be recognised as part of the problem in recalcitrant 
non-healing wounds and it might reflect the wound healing physiology better than any 
other sample material (Widgerow 2011). 
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Consequently, there are several inherent challenges in assaying chronic wound fluid. Very 
early comparisons between acute and chronic wound fluids showed a relevant difference in 
protease levels (Tarnuzzer and Schultz 1996) that has been confirmed by various authors 
subsequently (Chen et al. 1997; Moor, Vachon, and Gould 2009; Schmidtchen 2000). The 
issue of a proteolytic microenvironment in chronic wounds may be an important factor 
contributing to the non-healing phenotype, as growth factors and matrix components are 
subject to degradation (Widgerow 2011). This is not only true for growth factors and 
cytokines, but may also apply to receptors and signalling targets, which may thereby result 
in considerable loss of function. Therefore, merely quantifying analytes probably rather 
overestimates their protein bioactivity rather than reflecting the actual situation in the 
wound.  
The composition and texture of wound fluid is influenced by the amount of exudate 
produced over a defined period of time as well as by its evaporation and absorption. 
Similarly, general factors such as leg positioning and the hydration status of the patient 
significantly alter the quality of wound fluid (Trengove, Langton, and Stacey 1996). Years 
ago, it had already been shown that the wound fluid of healing chronic leg ulcers showed 
relevant differences in global components -such as albumin and total protein content- when 
compared to the wound fluid of non-healing ulcers (James et al. 2000). Albumin reflects the 
plasma compartment of wound exudate and is, therefore, influenced by vascular leakage or 
acute vascular injury as well as by intravascular pressure.  
When measuring protein biomarkers in wound fluid, the technical approach for how to 
obtain sample material must not be underestimated. It is still under discussion, whether 
values should be normalised to volume measures or total protein content for instance. 
Obtaining meaningful results is especially problematic when protease activity is high. 
Therefore, it is highly relevant to harvest immediate and unaltered sample material which is 
likely to reflect the original matrix of the wound microenvironment. In any cases, when 
intending to assess the amounts of peptide growth factors or other proteins in wound fluid, 
it should be recommended to determine the proteolytic activity of the environment in order 
to complete the picture. In this context, inert metabolites such as lactate might be considered 
advantageous since many of the limitations that apply to proteins do not apply here (Löffler 
et al. 2011).  
There has been rapid progress in analytic techniques and devices, which allow for the 
accurate and sensitive determination of wound fluid composition. On the other hand, the 
techniques and methods used to obtain wound fluid need to catch up with this pace and 
should be thoroughly re-evaluated with regard to the requirements that have to be met for 
producing sound and meaningful results. 
4. Protein arrays for the analysis of minute sample amounts  
The analysis of cytokines and matrix metalloproteinases in complex biological fluids 
requires sensitive, accurate and reliable methods. This is usually accomplished using 
classical solid phase sandwich immunoassays, such as ELISA (de Jager and Rijkers 2006). 
However these methods are characterised by high sample consumption and the single 
analysis of only one mediator per experiment. Due to the frequently found low exudate 
levels in chronic wounds along with the inherent complexity of wound fluid, appropriate 
technologies are needed to accurately and reliably determine multiple parameters with 
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minimal sample consumption. In this context, protein microarrays are important tools for 
the simultaneous detection and quantification of multiple parameters in complex biological 
mixtures, such as plasma (Cassatella et al. 1997) or tissue lysates (Beidler et al. 2008). This 
technology has been shown to exhibit high sensitivity and optimal signal to noise ratios 
even in the case of low target concentrations (Ekins 1989, 1998). 
There are two different types of microarray systems -planar and bead based arrays can be 
employed for multiplexed immunoassays. Whereas planar microarrays can be generated 
with hundreds and thousands of different capture spots, which are distinguished by their 
corresponding xy-coordinates, bead-based systems (e.g. Luminex) represent an interesting 
and flexible alternative, especially when the number of parameters to be determined in 
parallel is rather low. All bead-based array systems employ colour or size coded 
microspheres as solid support for the capture molecules. Beads are identified in a flow 
cytometer and the amount of captured target molecules is quantified on each individual 
bead using an appropriate reporter system. Sensitivity, reliability and accuracy are similar to 
those observed with standard ELISA procedures. Using bead-based technology, thousands 
of samples can be screened within a short time. Throughput neither seems to be a problem 
anymore, nor does sample volume (Stoll 2004; Templin et al. 2004).  
Inflammatory processes such as wound healing involve a complex network of 
immunoregulatory molecules such as chemokines, cytokines, proteases and their respective 
counter-regulatory mediators (Hahm, Glaser, and Elster 2011). The analysis of a complete 
set of mediators can therefore be considered to be of more value than the single analysis of 
only one single analyte (Gardy et al. 2009; de Jager et al. 2003). Although protein microarray 
technology has been successfully applied for the analysis of multiple analytes in complex 
biological mixtures -such as plasma, serum, urine and cerebrospinal fluid- publications 
using protein arrays for the analysis of wound status are rare (Hsu et al. 2008; Weigelt et al. 
2009; Craig-Schapiro et al. 2011; Swain et al. 2011). For instance, Grimstad et al. measured 
the concentration of 27 different cytokines in wound fluid derived from acute wounds using 
a bead-based system (Grimstad et al. 2011). Beidler et al. applied this technology to measure 
the concentrations of matrix metalloproteinases and cytokines in wound tissue lysate 
(Beidler et al. 2008, 2009). In combination with appropriate wound sampling procedures, the 
complex protein-composition of wound exudate together with limitations in the anticipated 
sample volume renders protein array technology -be it planar or bead-based- as an 
interesting tool for the analysis of wound-associated biomarkers (see section 6.1). Due to the 
inherent heterogeneity of wound exudate samples from chronic leg ulcers, the normalisation 
of the data needs to be discussed. In this context, the levels of albumin and total protein in 
wound fluid might represent an interesting reference value.  
5. Infection in the diabetic foot  
Foot pathologies are among the most frequent causes of hospitalisation in diabetic patients 
(Tecilazich, Dinh, and Veves 2011), with infection being the most dangerous complication. 
However, local processes triggered by microbial activity in the wound microenvironment 
have not gathered much interest until now. Apart from the classical means of diagnosing 
infection by clinical examination and microbiological swabbing, analysing wound fluid 
might provide additional important information. Furthermore, it is crucial to understand 
that microbiological sampling should be considered as a tool for proving the clinical 
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suspicion of infection rather than as a diagnostic instrument itself (Richard, Sotto, and 
Lavigne 2011). 
Diagnosing infection in diabetic foot ulcers is challenging. This is especially true when the 
clinical assessment is not conclusive. The clinical signs for the diagnosis of infection may 
even be diminished by comorbidities -such as peripheral arterial disease, impaired 
leukocyte function and neuropathy- thereby reducing local signs of inflammation (Edmonds 
2005; Williams, Hilton, and Harding 2004). However, since infection is a major cause of 
diabetes-related morbidity and mortality (Prompers et al. 2008) and as it paves the way 
towards limb amputation (Armstrong and Lipsky 2004), novel diagnostic tools that support 
prompt decision-making are urgently needed. 
Currently there is ample room for the misclassification and delayed treatment of infection in 
the diabetic foot, and many issues in diagnosing diabetic foot infections are left unsolved 
(Jeffcoate et al. 2008). Furthermore, infection can show rapid onset and progression in 
diabetic foot ulcers. 
In daily clinical practise, systemic markers of infection are the most established way of 
supporting the clinical suspicion of infection at present. The classical markers in this context 
include leukocyte count and C-reactive protein (CRP) as well as the erythrocyte 
sedimentation rate. Additionally, systemic markers specific to bacterial infection -such as 
procalcitonin, a peptide precursor of calcitonin, orosomucoid and haptoglobin- have been 
evaluated in serum of diabetic foot ulcers patients for the determination of infection 
(Jeandrot et al. 2008). Consecutively, a variety of immune mediators -including acute phase 
proteins, cytokines and chemokines- were examined in the plasma of patients with diabetic 
foot syndrome. These markers included CRP and fibrinogen as well as IL-6, IL-8, IL-18, 
macrophage inflammatory protein 1┙ (MIP1), interferon ┛-inducible protein-10 (IP10), 
macrophage migration inhibitory factor (MIF), macrophage chemoattractant protein 1 
(MCP1) and RANTES (Weigelt et al. 2009). Both of the studies just cited were able to connect 
the occurrence of certain systemic inflammatory markers with the presence of infection in 
the diabetic foot.  
In the first of these studies, serum CRP and procalcitonin were found to be significantly 
elevated during infection. CRP was discovered to be of a higher performance than 
procalcitonin, probably triggered by TNF┙, IL-6 and IL-1 derived from the site of 
inflammation (Jeandrot et al. 2008). Still, the diagnosis of infection was principally 
determined by clinical assessment and the treatment was chosen accordingly. 
Although various studies have been investigating CRP as a possible marker of infection in 
diabetic foot ulcers, sufficient support is not available for underlining its sole effectiveness 
(Dinh, Snyder, and Veves 2010) but it does add relevant supplementary information to the 
clinical assessment. 
In the study conducted by Weigelt et al., besides CRP both IL-6 and fibrinogen -as acute 
phase reactants- were observed to be associated with the severity of foot ulcerations (88% 
type 2 diabetics) but not with the grade of infection. The overall findings in this fairly large 
study population can be interpreted to underline a specific alteration of the immune status 
of in diabetic patients, opposed to a rather general immune activation (IL-6 |, CRP |, 
fibrinogen |, MIP1┙ |, MIF|, IP-10|, RANTES‾, MCP-1 }, IL-8} upon infection) (Weigelt 
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et al. 2009). This is a further important hint towards suspecting determined alterations in the 
immune response in diabetes, which may prove relevant to the future detection and 
assessment of diabetic foot ulcers. Anyhow, it should be noted that even low levels of most 
of the cytokines in circulation would reach toxic levels relatively fast, whereas -in principle- 
at their site of action in the local environment their levels can rise manifold higher. 
When analysing serological markers and cytokine patterns in wounds together with wound 
microbiology, local IL-6 concentrations are rather likely to support the clinical suspicion of 
infection than serological markers can. The analysis of local IL-6 and TNF┙ was shown to be 
able to discriminate between monomicrobial and polymicrobial infections in contrast to 
serum CRP and liposaccharide binding protein (LBP). Furthermore, local IL-6 was reported 
to reflect higher bacterial loads and infection, especially with pseudomonas (Ambrosch et al. 
2008). The determination of CRP as well as LBP as serological parameters, together with the 
semi-quantitative analysis of bacterial load and microbial identification, was performed. In 
this setting, the assessment of wounds was shifted to a first primary appraisal of 
microbiological rather than clinical examination. Although critical levels of bacterial loads in 
wounds have been proposed (Bowler, Duerden, and Armstrong 2001), the types of pathogen 
species are equally important. Nevertheless, in neuropathic diabetic foot ulcers the healing 
rate was also found to be inversely correlated with high bacterial loads (Xu et al. 2007). 
Furthermore, in a study by Ambrosch et al., a good correlation between local CRP and 
TNF┙ levels in wound washouts and tissue punch biopsies could be shown (Ambrosch et al. 
2008). 
In addition to the controversial findings on CRP, the upstream marker IL-6 seems to become 
even more meaningful in the local context. Overall, local alterations are likely to precede 
systemic changes. On the basis of this rationale, we advocate the investigation of the local 
microenvironment and possibly the correlation of these findings with circulatory markers. 
We are convinced that this local approach is more suitable for discovering useful markers 
for the assessment of infection in diabetic foot ulcer patients than the opposite approach of 
searching for alterations in the complicated circulatory proteome.  
Of course, this local approach is not always suitable as -for instance- in the acute Charcot 
foot, which is a widely unresolved problem in diabetic foot care. Notably in this context, it 
would be of great interest to find circulatory markers disclosing the disease state and having 
possible therapeutic implications on hand. Initial attempts have already been made in this 
direction (Mabilleau et al. 2011).  
6. Wound fluid - a window reflecting the wound microenvironment? 
The question of whether wound fluid could serve as a valuable window into the wound 
environment has already been asked -years ago- by Dorne R. Yager et al. (Yager, Kulina, and 
Gilman 2007). Therefore, it is not a novel aspect but it is indeed an exciting option for having 
a closer look into the wound microenvironment. Recently, it has even been proposed that 
the corrosive nature of the chronic wound environment and the continuous breakdown of 
the extracellular matrix mediated by proteases may link wound fluid directly to the 
phenotype of chronic non-healing wounds (Widgerow 2011). If this were the case, the 
science of assessing wound fluid should be an important stepping stone in obtaining access 
to the problem of chronic non-healing wounds. Wound fluid -which has been investigated 
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in a variety of studies- has added much to our understanding of wound healing. 
Nevertheless, to date there are neither techniques nor markers that have found their way 
into clinical practise.  
6.1 Biomarkers 
A biomarker can be defined as a substance that is used as an indicator of normal biological 
processes, pathologic conditions and therapeutic interventions (Hahm, Glaser, and Elster 
2011). They are widely attributed as playing a key role in the diagnosis, prognosis and 
clinical management of a broad range of disease states (Mueller, Muller, and Perruchoud 
2008). Prominent examples are prostate specific antigen (PSA) (Makarov et al. 2009), or Her-
2. However, due to complex disease pathologies and aetiological heterogeneity, it turns out 
that standalone markers are rather unlikely to be specific or else applicable on a wide-scale 
and a whole set of candidate markers are considered to be more promising e.g. as 
demonstrated by Domenici et al. (Domenici et al. 2010). According to Yager et al. there are 
as yet no accepted biomarkers, which allow the evaluation of the wound status and this 
critically hampers the improvement of appropriate treatments and effective therapies. 
Among the most promising candidate biomarkers are matrix metalloproteinases, cytokines 
and chemokines (Yager, Kulina, and Gilman 2007).  
6.2 Proteases and their inhibitors 
Chronic ulcers are characterised by a highly proteolytic microenvironment. Therefore, the 
four major biochemical classes of proteases (serine proteases, metalloproteinases, cysteine 
proteases and aspartic proteases) have generated great interest in the context of wound 
healing. In particular, matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) 
are critically involved in wound healing. Using protein array technology, Beidler et al. 
(Beidler et al. 2008) demonstrated that MMPs are differentially expressed in ulcerative and 
healthy tissue lysates. They demonstrated that MMP-8 and -9 in particular are strongly 
increased in ulcer tissue and decreased after the onset of the healing process. Yager et 
al.showed that MMP-2 and MMP-9 are elevated in chronic wound fluid compared with 
fluid from acute surgical wounds (Yager et al. 1996). Ladwig et al. (Ladwig et al. 2002) and 
Liu et al. (Liu et al. 2009) reported an increased ratio of MMP-9 to TIMP-1 in chronic non-
healing wound fluid compared with healing wounds. Together with the finding that the 
MMP2:TIMP-2 ratio is elevated in non-healing compared with healing leg ulcers (Mwaura et 
al. 2006), this suggests that a disturbed homeostasis between MMPs and TIMPs might be 
correlated with the non-healing status. Also, in chronic non-healing diabetic foot ulcers, 
MMPs and their inhibitors (TIMPs) have received much interest. In a study by Lobmann et 
al., higher concentrations of the MMPs -2, -8 and -9, in conjunction with lower 
concentrations of TIMP-2, were determined in tissue biopsies when comparing diabetic 
wounds to healthy controls (Lobmann et al. 2002). The study by Liu et al. extended these 
findings of elevated MMP-9 in diabetic foot ulcers to healing rates. Elevated MMP-9 -in 
these ulcers- was suggested to be linked to inflammatory processes and poor healing. 
Furthermore, in conjunction with low TIMP-1 and TGF┚, high MMP-9 was proposed as 
being indicative of poor wound healing (Liu et al. 2009). These findings are coincident with 
other previous findings - for instance, in pressure ulcers where diminished healing rates 
have been described in a high MMP-9/low TIMP-1 environment (Ladwig et al. 2002) and 
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with a slightly different setting regarding the MMP-9:TIMP-2 ratio in diabetic foot ulcers 
(Lobmann et al. 2006). The interconnection of elevated MMP-9/MMP-8 levels and poor 
healing has further been described in neuropathic diabetic foot ulcers, but furthermore here 
an association between high levels of MMP-1 and TIMP-1 and better healing rates has been 
shown (Muller et al. 2008). Recently, Widgerow proposed a theory focusing on neutrophil-
derived proteases -especially elevated MMP-9 in chronic wound fluid- as being involved in 
a vicious circle and stating that the corrosive nature of wound fluid was not only actively 
involved in matrix breakdown but also causative for non-healing a state probably further 
aggravated by bacterial factors (Widgerow 2011). According to this view, continued 
inflammation and leukocyte infiltration is triggered in chronic non-healing wounds, thereby 
perpetuating tissue destruction (Rayment, Upton, and Shooter 2008; cited by Widgerow 
2011). Together with an imbalance towards a proteolytic microenvironment and in 
conjunction with bacterial colonisation causing the continuous breakdown of extracellular 
matrix and growth factors, this milieu keeps wounds in a prolonged destructive state and so 
averts healing (Rayment, Upton, and Shooter 2008).  
In conclusion, we can see various overlapping motifs concerning an imbalance of MMPs and 
their inhibitory factors (TIMPs) in different types of wounds, which is also true for diabetic 
foot ulcers. MMPs seem to constitute some of the key players in this microenvironment and 
are probably linked to inflammatory activity and bacterial load, as well as the critical 
degradation of growth factors and extracellular matrix components. Nevertheless, as there 
are various MMPs involved in healing, such as MMP-1 to MMP-10, MMP-12 and MMP-13 
and several of their inhibitors (Armstrong and Jude 2002; Gill and Parks 2008); they are also 
important for physiological wound healing, although in a timely and ordinary fashion. As 
MMPs also have physiological roles and intimate links with inflammatory processes, an 
overview investigation of their roles with regard to inflammatory activity and wound 
healing rates would be desirable for coming to novel conclusions notably in non-healing 
wounds. For this endeavour, wound fluid might constitute a nearly ideal sample material.  
6.3 Cytokines and growth factors 
Besides MMPs, cytokines and chemokines are frequently discussed as potential indicators 
for the status of wound healing. In general, there is an ample variety of factors which can be 
found in the wound microenvironment and that play a role in wound healing. Nevertheless, 
the cytokines found in the local microenvironment are usually produced by local cells 
(Holzheimer and Steinmetz 2000) and may, therefore, provide us with interesting 
information on the local environment. The issue of mediators being found in wounds is 
already complex in physiological terms, and confounding factors -such as the chronic 
wound environment and exogenous factors from bacterial colonisation and the endogenous 
reactions to this scenario- make it even more complicated. Besides this, it is a fact that the 
pathogenesis of wound healing on the molecular level is poorly understood and may be 
diverse according to various different wound entities. Nevertheless, we will attempt a 
concise digression on the topic without the intent to give a comprehensive impression of 
chemokines, cytokines and growth factors in wound fluids. 
To our knowledge, there are no broad analyses available of these mediators in conjunction 
with clinical endpoints from chronic ulcers. Therefore, it may be prudent to begin with a 
glance at acute wound healing. 
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In a study by Grimstad et al. (already mentioned above) an attempt to characterise acute 
wound fluid from surgical drains at the first postoperative day after mastectomy was 
undertaken. This aspect therefore best describes the initial phase of the acute inflammatory 
response, which is particularly interesting in this relatively broad investigation assessing the 
levels of 27 different cytokines, chemokines and growth factors (Grimstad et al. 2011). 
Information as to this amount is generally scarce and will therefore be looked at in more 
detail here. In this context, the cytokines IL-6 and IL-8 -such as TNF┙ and IFN┛- were found 
in high abundance in acute wound fluid. In contrast with this pro-inflammatory pattern, the 
IL-1 receptor antagonist (IL-1RA) was also detected in high concentrations here. 
Interestingly, at this context the amounts of IL-1┚ detected and the anti-inflammatory 
cytokine IL-10 were found to be relatively low.  
This pattern just as observed in wound fluid at the onset of inflammation suggests a distinct 
but contained local inflammatory environment. The picture witnessed in this phase of 
wound healing can be interpreted -in our view- as an inflammatory response with strong 
inhibitory and restorative stimuli. This might be the case, as IL-8 constitutes a chemotactic 
factor for neutrophil recruitment (Baggiolini and Clark-Lewis 1992) as well as a factor 
promoting epidermal cell proliferation (Tuschil et al. 1992); moreover, IL-6 plays  an 
ambivalent role with pro- as well as anti-inflammatory properties, such as inhibiting TNF┙ 
and repressing IL-1┚ as well as inducing IL-1RA and IL-10 (Tilg et al. 1994). The low levels 
of the key pro-inflammatory marker IL-1┚, which is -for instance- associated with 
inflammasome activity and the control of infection (Schroder and Tschopp 2010) is also 
notable in this early postoperative setting.  
With regard to chronic non-healing wounds, a connection with persistent inflammatory 
activity is a guiding principle, which is observed in various entities of impaired healing 
(Acosta et al. 2008; Pukstad et al. 2010). In a longitudinal study in chronic venous leg ulcers, 
decreases in IL-1┙ and IL-1┚ were observed in healing ulcers, whereas increases in IL-8 and 
MIP-1┙ were associated with non-healing. This was observed in conjunction with decreased 
levels of toll-like receptor (TLR) activities in healing ulcers (Pukstad et al. 2010). The 
persistent activation of innate immune responses, in dividing the healing and non-healing 
entities of wounds by TLR activation and distinct cytokine patterns (IL-1┙ , IL1-┚, IL-8 
and MIP-1┙), may even be interpreted in favour of a constant bacterial challenge in non-
healers with relevant effects on the wound microenvironment. 
The elevated expression of IL-1┚ and excessive TNF┙ in non-healing wounds (Wallace and 
Stacey 1998) may, therefore, be linked to the distinct properties observed in this 
microenvironment. This may be the case, as high TNF┙ has been described not only as 
inducing IL-1┚ and its own synthesis but also their synergistic effects resulting in the 
suppression of extracellular matrix synthesis, whereas MMP synthesis is induced and TIMP 
synthesis is inhibited (Mast and Schultz 1996), thus contributing to persistent inflammatory 
activity and tissue destruction in diabetes (Nwomeh, Yager, and Cohen 1998; Naguib et al. 
2004). This link may, therefore, constitute a part of the vicious circle that we know of, 
linking alterations observed in the microenvironment of non-healing wounds to persistent 
inflammatory activity. 
For instance, levels of TNF┙ have been found to be elevated in non-healing compared to 
healing leg ulcers (Wallace and Stacey 1998). Trengove et al. found elevated levels of the 
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pro-inflammatory cytokines IL-1, IL-6 and TNF┙ in non-healing compared with healing 
ulcers and that these mediators decreased over the course of healing (Trengove, Bielefeldt-
Ohmann, and Stacey 2000). Beidler and co-workers measured 22 mediators in healthy and 
ulcerative tissue lysates and found that IL-1┙, IL-1┚, IL-4, IL-6, IL-8, IL-10, IL-12p40, G-CSF, 
GM-CSF, MCP-1, IFN┛, TNF┙, MIP-1┙, MIP-1┚ and TGF1 were expressed at significantly 
higher levels in ulcer tissue compared with healthy controls. Moreover, they found the 
analytes IL-1┙, IL-1┚, IFN┛, IL-12p40, GM-CSF and IL-1RA to be differentially expressed in 
rapid versus delayed healing ulcers (Beidler et al. 2009). 
In summary, there are promising candidates that might be used as indicators of the healing 
status of chronic and acute wounds. However, additional efforts are needed to further 
validate the existing candidates and to discover new potential biomarkers. In this context, 
the use of entire biomarker panels instead of standalone molecules should be taken into 
account. 
Especially in diabetes, it is established that a local over-secretion of pro-inflammatory 
cytokines (notably TNF┙, IL-6 and IL-1) is observed, impacting the wound healing 
microenvironment and opposing healing (Acosta et al. 2008). These factors have been 
multiply observed in the context of failure to heal and are linked with other processes 
observed in the wound environment, such as elevated proteolysis and the degradation of 
growth factors and their receptors.  
When it comes to growth factors, it is conceivable that beneath the mere abundance of these 
factors in wound fluid the aspect of bioactivity is of primary relevance. This may be best 
demonstrated by the reactions that have been described for ages, when comparing the 
diverse effects of wound fluids on cells in culture. The most important aspect of this may be 
the positive effect evoked by acute wound fluid on cellular proliferation. When acute 
wound fluid is added to cells in culture, increased proliferation of vascular endothelial cells, 
fibroblasts and endothelial cells was observed (Greenburg and Hunt 1978; Katz et al. 1991). 
Furthermore, the deposition of extracellular matrix and migration of cells are enhanced by 
acute wound fluid supplemented to cell cultures. In opposition to this, chronic wound fluid 
has been observed numerous times as inhibiting proliferation in vitro (Trengove, Bielefeldt-
Ohmann, and Stacey 2000; Bucalo, Eaglstein, and Falanga 1993; Phillips et al. 1998), thus 
hampering tissue restoration. Of course, the converse argument that the lack of proliferative 
stimulus in chronic wound fluid may be attributed to a mere lack of growth factors is 
invalid. To underline this thesis, Trengove et al. were not able to detect significant changes 
within the levels of platelet-derived growth factor (PDGF), epidermal growth factor (EGF), 
basic fibroblast growth factor (bFGF) or transforming growth factor beta (TGF┚) from 
healing and non-healing ulcers. However, in mitogenic assays in fibroblasts, wound fluid 
from healing ulcers was able to provoke a significantly enhanced proliferative response 
(Trengove, Bielefeldt-Ohmann, and Stacey 2000). Furthermore, additional growth factors 
have been implicated as playing an important role in wound healing, such as insulin-like 
growth factor (IGF) (Wagner et al. 2003) or keratinocyte growth factor (KGF) (Gibbs et al. 
2000). 
In a study by He et al., it was demonstrated that the addition of platelet derived growth 
factor (PDGF) to chronic wound fluid was able to synergistically enhance proliferation in 
fibroblasts, whereas chronic wound fluid alone also enhanced fibroblast proliferation at 
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lower levels (He et al. 1999). Nevertheless, the original matrix in this study was not 
preserved and the results suggest that essential factors can be found in wound fluid 
enhancing proliferation that can be stimulated by the addition of growth factors from 
external sources, whereas the original fluid matrix is suited to suppressing proliferative 
effects. To sum up the findings, a mere lack of growth factors does not seem to be 
responsible for impaired wound healing. In fact, other factors that characterise the wound 
environment seem to be of relevance in impairing local proliferation. For instance, it has 
been shown that high glucose levels are suited to inhibit fibroblast proliferation and to 
induce resistance to growth factors (Hehenberger and Hansson 1997). Furthermore, in 
fibroblasts from chronic diabetic wounds, lactate levels above 7 mM have been shown to 
abrogate cell proliferation as a specific effect of elevated L-lactate levels (Hehenberger et al. 
1998). Another aspect that may be of relevance within this context is the enhanced 
degradation of growth factors by proteases which is observed in chronic wound fluid when 
compared with its acute counterpart (Trengove et al. 1999). 
Eventually, cellular factors (such as reaching the end of their replicative life span, which was 
suggested for fibroblasts in chronic ulcers that had not healed for 3 years, and were non-
responding to PDGF while exhibiting a normal expression of their respective receptors 
compared to their normal counterparts) are another possibility that may explain the lack of 
proliferation (Agren et al. 1999) together with the demand for antecedent therapeutic 
intervention. Interestingly, this condition of environmentally-driven cellular aging has been 
shown not to be correlated with telomere shortening but to be induced by other factors; 
possibly decreased resistance to oxidative stress (Wall et al. 2008), including the possibility 
of reversing this induced phenotype. Nevertheless, fibroblast dysfunction in late non-
healing ulcers seems to constitute an important factor propagating this condition that cannot 
be overcome anymore by mere basic growth factor supplementation. 
6.4 Role of lactate 
Tissue lactate accumulates during the physiological course of healing to concentrations of ~ 
10-12 mM as opposed to 1–3 mM normally found in blood and most uninjured, resting 
tissues (Ghani et al. 2004). Even though it has been shown that these high lactate 
concentrations persist irrespective of tissue oxygenation (Ghani et al. 2004), the concept of 
lactate as a dead end product in hypoxia has survived for many years still. Nowadays, it is 
widely accepted that tissue lactate is mainly derived from aerobic glycolysis.  
Lactate is understood to have many fundamental metabolic and signalling functions 
(Gladden 2004). Thus, lactate enhances wound healing by the stimulation of extracellular 
matrix synthesis (Hussain, Ghani, and Hunt 1989; Green and Goldberg 1964) and 
angiogenesis (Beckert et al. 2006; Hunt et al. 2007). However, at higher concentrations these 
positive effects seem to deteriorate. In fibroblast experiments, a threshold for cell 
proliferation could be determined (Hehenberger et al. 1998). Cellular proliferation was 
enhanced so long as lactate levels were lower than this particular threshold but inhibited 
when raised above. 
In chronic wounds, tissue lactate concentrations reach far higher levels compared with acute 
wounds. Inflammatory cells that are ubiquitously present in chronic wounds cover their 
energy demand mainly through aerobic glycolysis and they generate lactate as a by-product 
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and in huge amounts. Next, lactate leaves the cytosol to the extracellular space by 
monocarboxylic transferases (MCT) (Gladden 2004).  
Almost every chronic wound is more or less subject to bacterial contamination. Even 
though bacterial contamination does not necessarily lead to immediate subsequent 
infection, wound healing is impaired when the bacterial load reaches a certain level. In 
addition, many bacterial strains that have been detected in chronic wounds -and in the 
diabetic foot in particular- cover their energy demand by fermentation, thus producing 
additional lactate. 
 
Fig. 1. Lactate levels in diabetic foot ulcers (DFU) with clinical signs of soft-infection are 
shown on the left side of the continuous line as opposed to non-infected DFU on the right. 
In addition, lactate concentrations of DFU that healed within a follow-up period of 6 months 
are given to the right of the dotted line. Further right, wound fluid lactate concentrations in 
surgical wounds are shown. Wound fluid lactate concentrations are given as box plots 
(median, minimum - maximum as well as the 25th and 75th percentiles). The respective 
median lactate concentrations are given above the corresponding box plots. The possible 
clinical implications of lactate are presented in coloured boxes (modified according to 
Löffler et al. 2011). 
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In diabetic foot ulcers, a correlation between elevated wound fluid lactate levels and the 
clinical signs of soft-tissue infection could be demonstrated. Wounds with clinical signs of 
soft-tissue infection showed significantly higher wound fluid lactate concentrations as 
opposed to those without soft-tissue infection. Out of the wound sub-population, without 
clinical signs of soft-tissue infection, wounds that healed within a 6 months follow-up 
period were characterised by wound fluid lactate concentrations comparable with those 
found in acute healing wounds (Löffler et al. 2011). In summary, elevated lactate levels seem 
to be attributed both to inflammatory and bacterial activity. Nevertheless, lactate is likely to 
favour healing unless its concentration exceeds a certain threshold. On the other hand, 
lactate in wound fluid might be a diagnostic marker both for impaired healing and soft-
tissue-infection (Figure 1).  
7. Conclusions 
Sampling and analysing wound fluid is an inherently challenging task, since a variety of 
local and systemic factors influence its composition. This is particularly true for chronic 
wounds and for diabetic foot ulcers. In addition, there is no clear consensus yet about how 
to obtain adequate sample material. It is important nevertheless, depending on the analysis 
intended to be undertaken to choose the appropriate technique for obtaining sample 
material. Hence, to obtain meaningful results an adequate and suitable technique for 
harvesting wound fluid is a major pre-requisite when considering using sophisticated 
analytic methods. The technical developments in this field have brought novel analytical 
opportunities that require only very little amounts of sample material in order to get 
meaningful results. A variety of techniques have been proposed for obtaining sample 
materials and a multitude of possible wound fluid markers have been investigated. Finding 
meaningful biomarkers or biomarker panels allowing for the instant detection of infection or 
the determination of wound healing tendencies are urgently needed (Hahm, Glaser, and 
Elster 2011). We are convinced that it does make sense to analyse potential biomarkers in 
wound fluid, which is both easily accessible and can be harvested in a non-invasive way. 
The obstacle to overcome here is to implement techniques suitable for daily clinical routines, 
allowing for fast and reliable diagnostic procedures. In this setting, there are less 
confounding factors to deal with as opposed to systemic markers. No systemic marker has 
been proven to be capable of serving as a standalone diagnostic tool yet. To date, however, 
no wound fluid marker has been established that might fill this gap neither. We are at the 
beginning of an era which might appreciate wound fluid analysis as a novel opportunity to 
get deeper insights into a complicated and widely unknown micro-environment. There is 
still substantial room for improvement and plenty of work has to be done before we are able 
to understand the elementary mechanisms of non-healing.  
8. Perspective 
Valuable markers for clinical wound assessment are urgently needed. Wound fluid 
biomarkers are probably the best option for reaching this aim. For this purpose, wound fluid 
components -such as proteases and their inhibitors as well as cytokines and growth factors 
and other elements associated with the local inflammatory response- are worthwhile 
investigating. The wound fluid degradation products of the extracellular matrix represent 
another interesting aspect in assessing the pathophysiology of non-healing wounds 
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(Moseley et al. 2004). This is by virtue of the fact that the course of chronic wound healing 
may be directly reflected in matrix turnover due to a highly proteolytic and pro-oxidative 
environment. In addition, markers of oxidative stress and simple metabolites such as lactate 
may also give us important information on the state of wound healing. However, there is 
still ample room for the discovery of both valuable and inert wound fluid biomarkers. It can 
be anticipated that novel technical opportunities along with reproducible sampling methods 
will bring forward new biomarkers, which may aid in future wound assessment. The need 
is there, especially in the diabetic foot, and hopefully meaningful studies will soon be under 
way to bridge this gap, thereby substantiating the valour of wound fluid diagnostics.  
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